Skip to main content
Erschienen in: Herz 7/2014

01.11.2014 | Original article

Assessment of arterial stiffness in chronic obstructive pulmonary disease by a novel method

Cardio-ankle vascular index

verfasst von: Dr. A.Ç. Aykan, T. Gökdeniz, F. Boyacı, İ Gül, E. Hatem, E. Kalaycıoğlu, T. Turan, H. Bektaş, M.B. Çilingir, D.A. Aykan, F. Ayyıldız, S. Altun

Erschienen in: Herz | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with chronic obstructive pulmonary disease (COPD) have an increased risk of cardiovascular morbidity and mortality. Increased arterial stiffness is associated with the presence and severity of cardiovascular disease. The cardio-ankle vascular index (CAVI) is a new method for assessment of arterial stiffness that is not influenced by blood pressure at the time of measurement and is significantly correlated with the presence and severity of cardiovascular disease. The aim of the present study was to evaluate whether there is an association between the spirometric severity of COPD, according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria, with arterial stiffness as assessed by CAVI.

Methods

We enrolled 123 patients with COPD (102 men) followed up by the chest medicine outpatient clinics and 35 healthy subjects (26 men). All patients were assessed with spirometry, CAVI, and clinical history.

Results

Patients with COPD had significantly increased CAVI values compared with control subjects (10.37 ± 2.26 vs. 6.74 ± 1.42, p < 0.001). CAVI was correlated with FEV1 % predicted, FEV1/FVC, and COPD stage (r: − 0.54, p < 0.001; r: − 0.58, p < 0.001 and r: 0.78, p < 0.001, respectively). Multivariate regression analysis showed that CAVI was independently associated with GOLD stages (p < 0.001).

Conclusion

In this study, we have shown that increased arterial stiffness assessed by CAVI is associated with the spirometric severity of COPD.
Literatur
1.
Zurück zum Zitat Huiart L, Ernst P, Suissa S (2005) Cardiovascular morbidity and mortality in COPD. Chest 128:2640–2646PubMedCrossRef Huiart L, Ernst P, Suissa S (2005) Cardiovascular morbidity and mortality in COPD. Chest 128:2640–2646PubMedCrossRef
2.
Zurück zum Zitat Mapel DW, Dedrick D, Davis K (2005) Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991–1999. COPD 2(1):35–41PubMedCrossRef Mapel DW, Dedrick D, Davis K (2005) Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991–1999. COPD 2(1):35–41PubMedCrossRef
3.
Zurück zum Zitat Hole DJ, Watt GC, Davey-Smith G et al (1996) Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 313:711–715PubMedCentralPubMedCrossRef Hole DJ, Watt GC, Davey-Smith G et al (1996) Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 313:711–715PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Willum-Hansen T, Staessen JA, Torp-Pedersen C et al (2006) Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113:664–670PubMedCrossRef Willum-Hansen T, Staessen JA, Torp-Pedersen C et al (2006) Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113:664–670PubMedCrossRef
5.
Zurück zum Zitat Kozlov S, Balachonova T, Machmudova H et al (2012) Carotid atherosclerosis, endothelial dysfunction, and arterial stiffness in young and middle-aged men with coronary artery disease. Int J Vasc Med 2012:950130PubMedCentralPubMed Kozlov S, Balachonova T, Machmudova H et al (2012) Carotid atherosclerosis, endothelial dysfunction, and arterial stiffness in young and middle-aged men with coronary artery disease. Int J Vasc Med 2012:950130PubMedCentralPubMed
6.
Zurück zum Zitat Shirai K, Hiruta N, Song M et al (2011) Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb 18(11):924–938PubMedCrossRef Shirai K, Hiruta N, Song M et al (2011) Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb 18(11):924–938PubMedCrossRef
7.
Zurück zum Zitat Rabe KF, Hurd S, Anzueto A et al (2007) Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6):532–555PubMedCrossRef Rabe KF, Hurd S, Anzueto A et al (2007) Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6):532–555PubMedCrossRef
8.
Zurück zum Zitat Punturieri A, Croxton TL, Weinmann GG, Kiley JP (2008) Chronic obstructive pulmonary disease: a view from the NHLBI. Am J Respir Crit Care Med 178:441–443PubMedCentralPubMedCrossRef Punturieri A, Croxton TL, Weinmann GG, Kiley JP (2008) Chronic obstructive pulmonary disease: a view from the NHLBI. Am J Respir Crit Care Med 178:441–443PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Reed RM, Eberlein M, Girgis RE et al (2012) Coronary artery disease is under-diagnosed and under-treated in advanced lung disease. Am J Med 125(12):1228.e13–1228.e22PubMedCentralPubMedCrossRef Reed RM, Eberlein M, Girgis RE et al (2012) Coronary artery disease is under-diagnosed and under-treated in advanced lung disease. Am J Med 125(12):1228.e13–1228.e22PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Masugata H, Senda S, Okuyama H et al (2009) Comparison of central blood pressure and cardio-ankle vascular index for association with cardiac function in treated hypertensive patients. Hypertens Res 32:1136–1142PubMedCrossRef Masugata H, Senda S, Okuyama H et al (2009) Comparison of central blood pressure and cardio-ankle vascular index for association with cardiac function in treated hypertensive patients. Hypertens Res 32:1136–1142PubMedCrossRef
11.
Zurück zum Zitat Ibata J, Sasaki H, Kakimoto T et al (2008) Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabetes Res Clin Pract 80:265–270PubMedCrossRef Ibata J, Sasaki H, Kakimoto T et al (2008) Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabetes Res Clin Pract 80:265–270PubMedCrossRef
12.
Zurück zum Zitat NoikeH, Nakamura K, Sugiyama Y et al (2010) Changes in cardio-ankle vascular index in smoking cessation. J Atheroscler Thromb 17:517–525CrossRef NoikeH, Nakamura K, Sugiyama Y et al (2010) Changes in cardio-ankle vascular index in smoking cessation. J Atheroscler Thromb 17:517–525CrossRef
13.
Zurück zum Zitat Park HE, Choi SY, Kim MK, Oh BH (2012) Cardio-ankle vascular index reflects coronary atherosclerosis in patients with abnormal glucose metabolism: assessment with 256 slice multi-detector computed tomography. J Cardiol 60(5):372–376PubMedCrossRef Park HE, Choi SY, Kim MK, Oh BH (2012) Cardio-ankle vascular index reflects coronary atherosclerosis in patients with abnormal glucose metabolism: assessment with 256 slice multi-detector computed tomography. J Cardiol 60(5):372–376PubMedCrossRef
14.
Zurück zum Zitat Gökdeniz T, Turan T, Aykan AÇ et al (2013) Relation of epicardial fat thickness and cardio-ankle vascular index to complexity of coronary artery disease in nondiabetic patients. Cardiology 124(1):41–48PubMedCrossRef Gökdeniz T, Turan T, Aykan AÇ et al (2013) Relation of epicardial fat thickness and cardio-ankle vascular index to complexity of coronary artery disease in nondiabetic patients. Cardiology 124(1):41–48PubMedCrossRef
15.
Zurück zum Zitat Maclay JD, McAllister DA, Mills NL et al (2009) Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180(6):513–520PubMedCrossRef Maclay JD, McAllister DA, Mills NL et al (2009) Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180(6):513–520PubMedCrossRef
16.
Zurück zum Zitat Reboul C (2005) Chronic hypoxia exposure depresses aortic endothelium dependent vasorelaxation in both sedentary and trained rats: involvement of L-arginine. J Appl Physiol 99:1029–1035PubMedCrossRef Reboul C (2005) Chronic hypoxia exposure depresses aortic endothelium dependent vasorelaxation in both sedentary and trained rats: involvement of L-arginine. J Appl Physiol 99:1029–1035PubMedCrossRef
17.
Zurück zum Zitat Agusti AG (2005) Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:367–370PubMedCrossRef Agusti AG (2005) Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:367–370PubMedCrossRef
18.
Zurück zum Zitat Janner JH, McAllister DA, Godtfredsen NS et al (2012) Is chronicobstructive pulmonary disease associated with increased arterial stiffness? Respir Med 106(3):397–405PubMedCrossRef Janner JH, McAllister DA, Godtfredsen NS et al (2012) Is chronicobstructive pulmonary disease associated with increased arterial stiffness? Respir Med 106(3):397–405PubMedCrossRef
19.
Zurück zum Zitat Fantin F, Mattocks A, Bulpitt CJ et al (2007) Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing 36(1):43–48PubMedCrossRef Fantin F, Mattocks A, Bulpitt CJ et al (2007) Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing 36(1):43–48PubMedCrossRef
20.
Zurück zum Zitat McAllister D, Maclay J, Mills N et al (2007) Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:1208–1214PubMedCentralPubMedCrossRef McAllister D, Maclay J, Mills N et al (2007) Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:1208–1214PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Maclay JD, McAllister DA, Rabinovich R et al (2012) Systemic elastin degradation in chronic obstructive pulmonary disease. Thorax 67(7):606–612PubMedCrossRef Maclay JD, McAllister DA, Rabinovich R et al (2012) Systemic elastin degradation in chronic obstructive pulmonary disease. Thorax 67(7):606–612PubMedCrossRef
22.
Zurück zum Zitat Yasmin, McEniery CM, Wallace S (2005) Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 25:372–378PubMedCrossRef Yasmin, McEniery CM, Wallace S (2005) Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 25:372–378PubMedCrossRef
Metadaten
Titel
Assessment of arterial stiffness in chronic obstructive pulmonary disease by a novel method
Cardio-ankle vascular index
verfasst von
Dr. A.Ç. Aykan
T. Gökdeniz
F. Boyacı
İ Gül
E. Hatem
E. Kalaycıoğlu
T. Turan
H. Bektaş
M.B. Çilingir
D.A. Aykan
F. Ayyıldız
S. Altun
Publikationsdatum
01.11.2014
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe 7/2014
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-013-3902-3

Weitere Artikel der Ausgabe 7/2014

Herz 7/2014 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.